Back to Journals » OncoTargets and Therapy » Volume 15

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer

Total article views   HTML views PDF downloads Totals
3,689 Dovepress* 3,532+ 152 3,684
PubMed Central* 157 56 213
Totals 3,689 208 3,897
*Since 12 September 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar